InvestorsHub Logo
Followers 134
Posts 3756
Boards Moderated 0
Alias Born 01/28/2006

Re: biodoc post# 216862

Saturday, 02/10/2018 1:44:54 PM

Saturday, February 10, 2018 1:44:54 PM

Post# of 403461
Your statement may be framing Leo's dilemma.

"Of course I'm looking for enough cash to further advance IPIX but I am very focused on the quality of the partner. I would prefer a deal with a BP over a regional player for limited rights. I am certainly not opposed to a straight acquisition on good terms by a non big name entity."

I think it is safe to assume IPIX is talking to multiple potential partners. Their dilemma is how to structure the best deal. Big pharma companies may have more to offer as partners but their financial offers may not be as high as smaller niche players. Another dilemma is an out right sale vs a comprehensive partnership for all 3 drugs vs multiple partners for all 3 drugs with multiple licensing agreements for different indications and geographic regions.

I feel we are close to partnership offers. I expect them to be announced after the Prurisol data is released.

Farrell
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News